HealthcareNSE · BSE

Ajanta Pharma Ltd.

AJANTPHARM · ISIN INE031B01049

Share price

₹3,044▼ -0.34%

Market capitalisation

₹38030 Cr● Closed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹38030 Cr

Current price

₹3,044

-0.34% today

52W high

₹3,315

52W low

₹2,330

Stock P/E

35.98

P/B ratio

8.4

02 · Per share & returns

EPS (TTM)

₹84.61

Book value

₹362

ROE

25.39%

ROA

14.82%

Dividend yield

1.83%

Beta

0.2

03 · Financials (TTM)

By the numbers

Revenue

₹5453 Cr

+21.50% YoY

EBITDA

₹1498 Cr

Net profit

₹1056 Cr

+18.60% YoY

Profit margin

19.37%

Operating margin

23.19%

Total debt

₹260 Cr

Total cash

₹665 Cr

Debt / equity

0.06x

Current ratio

2.64x

Payout ratio

33.13%

04 · Analyst view

Target price

₹3,303

Upside

+8.52%

Consensus

STRONG BUY

Analysts

05 · Shareholding pattern

Who owns AJANTPHARM?

Promoters
66.25%
Founders & promoter group
Institutions
21.59%
FII + DII
Public
12.15%
Retail & non-institutional

As of 31 Mar 2026 · Source: NSE corporate filings

06 · Registration & listing

On the record

Symbol: AJANTPHARM
Exchange: NSE · BSE
CIN: —
ISIN: INE031B01049
BSE code: 532331
Sector: Healthcare
Industry: Healthcare
Face value: ₹2
Listing date: 28 May 2000
Employees: —
Headquarters: Mumbai, India
Website: www.ajantapharma.com

07 · About

What is Ajanta Pharma Ltd.?

Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic areas comprising cardiology, dermatology, ophthalmology, and pain management. The company operates in India, Africa, Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.

08 · Common questions

Frequently asked

What is the CIN of Ajanta Pharma Ltd.?+

The Corporate Identity Number for Ajanta Pharma Ltd. is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Ajanta Pharma Ltd.?+

Promoter holding in AJANTPHARM is approximately 66.25%, as disclosed in the latest published shareholding pattern.

What is the market capitalisation of Ajanta Pharma Ltd.?+

Ajanta Pharma Ltd. (AJANTPHARM) has a market capitalisation of approximately ₹38030 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent